secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPACT BIOMEDICAL INC. (IBO)
CIK:        0001834105
Form:       8-K
Filed at:   2026-09-16T22:05:39+00:00
Accession:  0001493152-26-042975
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Impact Biomedical: Zoar files Form F-4 for merger; closing still subject to SEC, shareholder vote, listing
--------------------------------------------------------------------------------

- Zoar Limited filed Form F-4 with SEC on Sept 10, 2026 for proposed merger with Impact Biomedical (NYSE: IBO).
- Combined company to focus on active pharmaceutical ingredients and intermediates for therapeutic areas.
- Completion requires SEC effectiveness, Impact stockholder approval, and NYSE American listing of PubCo ordinary shares.
- Preliminary proxy statement/prospectus included; definitive version to be mailed after effectiveness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834105/000149315226042975/0001493152-26-042975-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834105/000149315226042975/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042975

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer